This inventor holds 1 USPTO granted patent. Top assignee: Ems S.a.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Rodolfo Camargo: Innovator in Antibacterial Compounds
Introduction
Rodolfo Camargo is a notable inventor based in Araraquara, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial and antiprotozoal compounds. His work focuses on creating innovative solutions that address critical health challenges.
Latest Patents
Rodolfo holds a patent for "Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines." This patent describes nitroimidazolic derivative compounds that exhibit potent antibacterial and antiprotozoal activity, functioning as effective urease inhibitors. The application outlines the process for synthesizing these compounds and their potential applications in pharmaceutical formulations.
Career Highlights
Rodolfo Camargo is associated with Ems S.A., a company known for its commitment to innovation in the pharmaceutical sector. His work has led to advancements in the development of new medications that can significantly improve patient outcomes. With a focus on research and development, he continues to contribute to the field through his innovative ideas and solutions.
Collaborations
Rodolfo has collaborated with talented individuals such as Jean L Santos and Andressa Munhoz. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to more effective pharmaceutical solutions.
Conclusion
Rodolfo Camargo is a distinguished inventor whose work in antibacterial compounds has the potential to make a significant impact in the pharmaceutical industry. His innovative approach and dedication to research continue to drive advancements in healthcare.